Preimplantation genetic diagnosis and therapy in humans- Opportunities and risks
IntroductionPreimplantation Genetic Diagnosis (PGD) was developed in the 1990s and has been used since to diagnose and discard embryos with genetic conditions or chromosomal abnormalities. CRISPR-Cas9 was discovered in 2012 and has been used in research, but has not become clinical practice on human...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Örebro universitet, Institutionen för medicinska vetenskaper
2020
|
| Subjects: | |
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-81532 |